Smartleaf Asset Management LLC Has $43,000 Position in Select Medical Holdings Co. (NYSE:SEM)

Smartleaf Asset Management LLC increased its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 179.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,296 shares of the health services provider’s stock after buying an additional 1,473 shares during the period. Smartleaf Asset Management LLC’s holdings in Select Medical were worth $43,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Phocas Financial Corp. bought a new position in shares of Select Medical during the fourth quarter worth about $285,000. Illinois Municipal Retirement Fund increased its position in Select Medical by 3.3% during the 4th quarter. Illinois Municipal Retirement Fund now owns 60,840 shares of the health services provider’s stock valued at $1,147,000 after purchasing an additional 1,939 shares during the period. Hussman Strategic Advisors Inc. bought a new position in Select Medical during the 4th quarter worth approximately $2,375,000. Handelsbanken Fonder AB lifted its position in shares of Select Medical by 19.9% in the 4th quarter. Handelsbanken Fonder AB now owns 23,511 shares of the health services provider’s stock worth $443,000 after purchasing an additional 3,900 shares during the period. Finally, New York State Common Retirement Fund boosted its stake in shares of Select Medical by 17.6% in the 4th quarter. New York State Common Retirement Fund now owns 47,244 shares of the health services provider’s stock valued at $891,000 after purchasing an additional 7,067 shares during the last quarter. 89.48% of the stock is owned by institutional investors.

Select Medical Price Performance

Shares of NYSE SEM opened at $16.99 on Wednesday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm’s 50-day moving average price is $18.88 and its 200-day moving average price is $26.62. The firm has a market capitalization of $2.19 billion, a P/E ratio of 10.29, a P/E/G ratio of 0.64 and a beta of 1.56. Select Medical Holdings Co. has a 1-year low of $16.20 and a 1-year high of $40.98.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Equities research analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.47%. The ex-dividend date is Monday, March 3rd. Select Medical’s dividend payout ratio (DPR) is presently 15.15%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a report on Monday, February 24th. UBS Group dropped their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Royal Bank of Canada decreased their target price on Select Medical from $47.00 to $23.00 and set an “outperform” rating for the company in a research note on Monday, February 24th. Finally, StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.